316 related articles for article (PubMed ID: 19491840)
1. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
Hernandez B; Hasson NK; Cheung R
Am J Gastroenterol; 2009 Aug; 104(8):1961-7. PubMed ID: 19491840
[TBL] [Abstract][Full Text] [Related]
2. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
[TBL] [Abstract][Full Text] [Related]
4. Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.
Tenner CT; Herzog K; Chaudhari S; Bini EJ; Weinshel EH
Int J Clin Pract; 2012 Oct; 66(10):1009-13. PubMed ID: 22994334
[TBL] [Abstract][Full Text] [Related]
5. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
Myers RP; Gregor JC; Marotta PJ
Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
[TBL] [Abstract][Full Text] [Related]
8. A comparison of hepatitis A and hepatitis B measures among vaccinated and susceptible online men who have sex with men.
Gilbert LK; Levandowski BA; Scanlon KE; Peterson RS
Int J STD AIDS; 2010 Jun; 21(6):400-5. PubMed ID: 20606219
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students.
Jabłkowski M; Kuydowicz J; Strzelczyk J; Białkowska J
Med Sci Monit; 2002 Nov; 8(11):CR762-6. PubMed ID: 12444381
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.
Laurence JC
Am J Med; 2005 Oct; 118 Suppl 10A():75S-83S. PubMed ID: 16271546
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
Chen H; Cantrell CR
Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
[TBL] [Abstract][Full Text] [Related]
14. Experience with hepatitis A and B vaccines.
Davis JP
Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
[TBL] [Abstract][Full Text] [Related]
15. Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
Kramer JR; Hachem CY; Kanwal F; Mei M; El-Serag HB
Hepatology; 2011 Jan; 53(1):42-52. PubMed ID: 21254161
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
17. Overcoming obstacles to immunization in patients with chronic liver disease.
Bockhold K; Riely CA; Jeffreys C
Am J Med; 2005 Oct; 118 Suppl 10A():40S-45S. PubMed ID: 16271540
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis vaccination and prophylaxis.
Nguyen CT; Tran TT
Clin Liver Dis; 2009 May; 13(2):317-29. PubMed ID: 19442921
[TBL] [Abstract][Full Text] [Related]
19. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
Keystone JS; Hershey JH
Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
[TBL] [Abstract][Full Text] [Related]
20. Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia.
Yetgin S; Tavil B; Aytac S; Kuskonmaz B; Kanra G
Leuk Res; 2007 Apr; 31(4):493-6. PubMed ID: 16930691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
